• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Increased Risk of Transfusion Reactions in Postpartum Blood Transfusions

August 28, 2019

Transfusion reactions occur in 0.15% to 3.7% of all transfusions and can range from mild fevers to severe, life-threatening reactions. Since pregnancy is associated with changes in the immune system, researchers in Sweden sought to determine whether transfusion reactions are more common in postpartum blood transfusions. Based on data from the Swedish National Birth Registry, which is linked to the Stockholm Transfusion Database, 517,854 pregnant women were identified of which 2.4% (12,183) received a blood transfusion postpartum. Ninety-six transfusion reactions occurred in the study cohort (79 per 10,000 pregnant women), which was higher compared to non-pregnant women of similar ages who received blood transfusions in Sweden (40 per 10,000 non-pregnant women) (odds ratio, 2.0; 95% CI, 1.6-2.5). Preeclampsia, induction of labor, or a premature delivery are associated with increased risk for a transfusion reaction. These findings underscore the need to carefully monitor postpartum women for transfusion reactions.

Reference: Thurn L, Wikman A, Westgren M and PG Lindqvist. Incidence and risk factors of transfusion reactions in postpartum blood transfusions. Blood Advances 2019; 3(15); 2298-2306.

Filed Under

  • Adverse Events (non-infectious)
  • News
  • Special Transfusion Situations

Recommended

  • AABB and the CDC Outline Guidelines for Laboratory Testing of Patients with Suspected Ebola

  • RBCs from Female Donors are Not Associated with Increased Mortality among Transfusion Recipients

  • Studies Find Variable Anti-SARS-CoV-2 Antibody Responses

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Gene Editing of HBG1 and HBG2 Promotors to Treat β-Thalassemia and Sickle Cell Disease

  • Jehovah’s Witness Governing Body Allows Autologous Transfusions

  • RBC Exchange Transfusion for Patients with Severe Babesiosis

  • Oropouche Virus RNA Detected in Blood Donors in Brazil

    Question of the Day

    Copyright © 2026 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley